Allison Ng
Family Medicine · Cincinnati, OHNPI 1851788731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 42.4% of the total. Reporting peaked in 2024 at $937 and has fallen 56.9% since, to $404 in 2025.
Across 129 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Exact Sciences$154
- Cranial Technologies, Inc$136
- Lilly USA, LLC$136
- Hologic Sales And Service, LLC$122
- GSK$103
- plus $731 from 18 others
What the payments were for
- Travel & lodging$10%
- Food & beverage$2,37099%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $1,017 |
| Exact Sciences | 6 | $154 |
| Cranial Technologies, Inc | 8 | $136 |
| Lilly USA, LLC | 10 | $136 |
| Hologic Sales And Service, LLC | 3 | $122 |
| GSK | 6 | $103 |
| Merck | 5 | $94 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $78 |
| Bayer | 4 | $76 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| AstraZeneca | 4 | $57 |
| Alkermes, Inc. | 2 | $49 |
| Gilead | 2 | $40 |
| Insulet Corporation | 2 | $37 |
| Pfizer | 2 | $33 |
| Novo Nordisk | 2 | $33 |
| Indivior Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Dexcom, Inc. | 2 | $26 |
| Sage Therapeutics, LLC | 1 | $20 |
| VBI Vaccine (delaware) Inc. | 1 | $20 |
| Abbott | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
How this compares
$2,399 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 29 | $37,205 |
| OzempicSemaglutide | 20 | $27,517 |
| MounjaroTirzepatide | 19 | $17,889 |
| JardianceEmpagliflozin | 18 | $16,850 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $16,234 |
| EliquisApixaban | 15 | $13,163 |
| Spiriva HandihalerTiotropium Bromide | 11 | $7,657 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,502 |
| Gabapentin | 97 | $1,505 |
| Duloxetine Hcl | 25 | $1,317 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $782 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $668 |
| Atorvastatin Calcium | 92 | $546 |
| Buspirone Hcl | 18 | $543 |
| Azelastine Hcl | 16 | $539 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $136 | $55,09448 claims |
| Novo NordiskOzempic | $33 | $27,51720 claims |
| GSKTrelegy Ellipta | $103 | $16,23414 claims |
| PfizerEliquis | $33 | $13,16315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Cincinnati
- Michael HeileCincinnati$272K
- Amy MechleyCincinnati$120K
- Melissa SchroerCincinnati$116K
- William CoxCincinnati$23K
- Jeffrey SusmanCincinnati$21K
- Ginger KubalaCincinnati$19K
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.